News Digest / Ticker: BAYN.DE

Ticker: BAYN.DE

04:15am, Wednesday, May 06, 2026

Bayer Moves to Acquire Perfuse Therapeutics in Deal Worth Up to $2.45 Billion

Bayer announces plan to acquire biopharma company Perfuse Therapeutics for up to $2.45 billion, expanding its ophthalmology portfolio with promising glaucoma and diabetic retinopathy drug in phase II trials.

04:33am, Monday, Mar 24, 2025

Georgia Court Orders Bayer to Pay $2.1 Billion Over Roundup: What Traders Need to Know About This Legal Bombshell